Leerink Lowers PT after Ironwood Pharmaceuticals (IRWD) 1Q Results

May 6, 2015 11:00 AM

Leerink Partners reiterates a Market Perform rating on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and lowers its price target to $16 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found